MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP22F5033 to DMS Pharmaceutical Group Inc. under delivery order SPE2DX15D9383 for the procurement of Meloxicam Tablets. The initial award amount was established at 4,999,999.00 dollars. This federal action was processed through the Department of Defense and posted on the DIBBS platform with an award date of May 28, 2026. A subsequent modification, P00001, was signed and became effective on May 28, 2026, resulting in the cancellation of CLIN 0001 at no cost. This modification reduced the total order amount by 3.01 dollars because the material was no longer required due to a ship decommissioning scheduled for September 2026. The contract adheres to standard FAR clauses and commercial item solicitation terms.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
